← Back to headlines
Betting on Clinical Trials Sparks Controversy
Platforms like Kalshi and Polymarket are facing criticism for allowing bets on clinical trial outcomes, with researchers warning of potential insider trading and interference with drug development.
7 Aug, 10:00 — 7 Aug, 10:00
